Is It Too Late to Get In On This Millionaire-Making Stock?

Is It Too Late to Get In On This Millionaire-Making Stock?

This is an amazing biotech with multiple drugs in pivotal trials. The U.S. Food and Drug Administration (FDA) has named this drug a breakthrough therapy in two indications: major depressive disorder and agitation caused by Alzheimer's Disease. Axsome is prepping its new drug application (NDA) right now for AXS-05 to treat major depressive disorder.